Impact Analysis: Ruling on Trade Secret Particularity (Quintara Biosciences v. Ruifeng Biztech)
Last summer the U.S. Court of Appeals for the Ninth Circuit issued a pivotal ruling in Quintara Biosciences, Inc. v. Ruifeng Biztech, Inc. that significantly alters the landscape of federal trade secret litigation. The court held that the Defend Trade Secrets Act (DTSA) does not require a plaintiff to identify allegedly misappropriated trade secrets with […]
